Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Galapagos NV

www.glpg.com

Industriepark Mechelen Noord
Generaal de Wittelaan
L11 A3 Mechelen
B-2800
Belgium

+32 15 34 29 00

Activities

Research & Development | Pharmaceutical

Related Companies

  • Icrom SRL
  • Nanoform
  • Starlab
  • PCI Pharma Services
  • Solvias
  • Piramal Pharma Solutions
  • Butterworth Laboratories
  • Hermes Pharma GmbH
  • Ecolab Life Sciences
  • Vectorbuilder Inc
  • Rentschler Biopharma SE
  • Indena
  • Quotient Sciences
  • ProtaGene
  • Actylis – The Partner of Choice

Related Content

Galapagos expands fibrosis portfolio
Galapagos expands fibrosis portfolio
Pharnext announces R&D agreement with Galapagos
Pharnext announces R&D agreement with Galapagos
Galapagos ends inflammation partnership with Janssen
Galapagos ends inflammation partnership with Janssen
AbbVie and Galapagos to co-develop cystic fibrosis therapies
AbbVie and Galapagos to co-develop cystic fibrosis therapies
Galapagos appoints CEO of Service Division
Galapagos appoints CEO of Service Division
Galapagos receives €2.5m grant for IBD research
Galapagos receives €2.5m grant for IBD research
Galapagos acquires Cangenix, a structure-based drug discovery company
Galapagos acquires Cangenix, a structure-based drug discovery company
Galapagos receives €2.7m IWT grant for antibacterial research
Galapagos receives €2.7m IWT grant for antibacterial research
Galapagos discovers novel class of antibiotics
Galapagos discovers novel class of antibiotics
BioFocus and Ono sign CNS drug discovery agreement
BioFocus and Ono sign CNS drug discovery agreement
University of Edinburgh to collaborate with Galapagos on cancer therapies
University of Edinburgh to collaborate with Galapagos on cancer therapies
Almirall agrees research alliance with BioFocus
Almirall agrees research alliance with BioFocus
Galapagos and Genentech extend drug discovery deal
Galapagos and Genentech extend drug discovery deal
Evotec acquires compound management business
Evotec acquires compound management business
Galapagos receives €4m in milestones from Servier
Galapagos receives €4m in milestones from Servier
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company